| Specification |
22.2% |
Usage |
Antiparasitic |
| Raw Material |
Fenbendazole |
Species |
Cattle, sheep, swine, camels,chicken |
| Dosage Form |
Granules |
Sample |
Yes |
| Packing |
1kg/bag, 10bags/carton
25kg/bag/drum |
Delivery Time |
15-20days |
| MOQ |
500KG |
Payment Term |
T/T, D/P, D/A, L/C |
| GMP |
Yes |
ISO9001 |
Yes |
| FDA |
Yes |
COS |
Yes |
Product Description
Fenbendazole granules
Pharmacology and Mechanism of Action
Benzimidazole antiparasitic drug. Like other benzimidazoles, fenbendazole produces a degeneration of the parasite microtubule and irreversibly blocks glucose uptake in parasites. Inhibition of glucose update causes depletion of energy stores in parasite, eventually resulting in death. However, there is no effect on glucose metabolism in mammals.
Indications and Clinical Uses
Fenbendazole is effective for treatment of numerous helminth intestinal parasites in animals, including Toxacara, Toxascaris, Ancylostoma, and Trichuris. In dogs it is effective for most intestinal helminth parasites and also against nematodes.
Fenbendazole has been effective for treatment of Giardia, but higher doses are needed and there may be failure rates as high as 50%. It is effective in cats for treatment o f lungworms, flukes, and a variety of helminth parasites.
Precautionary Information
Adverse reactions and side effects
It has a good safety margin, but vomiting and diarrhea have been reported. When evaluated at dose of three and five times the recommended dose at three times the recommended duration, fenbendazole was well tolerated and no adverse effects were reported. It has been safe to use during pregnancy. There have been rare reports of pancytopenia associated with fenbendazole administration.
Contraindications and precautions
No known contraindications. It may be used in all ages of animals.
Drug interactions
There are no known drug interactions.
Stability and Storage
Store in a tightly sealed container, protected from light, and at room temperature. Stability of compounded formulations has not been evaluated.
Packing: 25kg/bag/drum
Company Profile
Hebei Veyong pharmaceutical Co., Ltd., was established in 2002, located in Shijiazhuang City Hebei Province, China, near the Capital Beijing. It's a large GMP-certified veterinary druo enterprise, with R&D, production and sales of veterinary APlspreparations premixed feeds and feed additives. As Provincial Technical CenterVeyong has established an innovated R&D system for new veterinary drug, and is the nationally knowntechnological innovation-based veterinary enterprise. Veyong has two production bases: Shijiazhuang and Ordos, with 7APl production lines including lvermectin, Eprinomectin, Tiamulin Fumarateects and 12 preparation production lines including injection, oral solution, powder, premix, bolus, pesticides and disinfectant ect. Veyong provides APls, more than 100 own-label preparations and OEM & ODM service.
Vevong established the comolete auality manaement svstem, obtained the ISO9001 certificate, China GMP certificate, Australia APVMA GMP certificate, Ethiopia GMP certificate, Ivermectin CEP certificate, and passed US FDA inspection. Veyong has professional team of registeration, sales and technica service, has made long term cooperation with many internationally known animal pharmaceutical enterprises with products exported to the Europe, South America, Middle East, Africa, Asia, etc. more than 60 countries and regions.
Veyong attaches great importance to the management of EHS (Environment Health & Safety) system, and obtained the lSO14001 and OHSAS18001 certificates. Veyong ha been listed in the strategic emerging industrial enterprises in Hebei Province and can ensure the continuous supply ofproducts.
Vevong takes "Maintain animal health, improve quality of life"as the mission, strives to become the most valuable veterinary drug brand, and looks forward to active cooperation with global customers.
Prodution workshop:
Warehouse:
Laboratory:
Audited Supplier 
){kind=link}
){kind=link}